Sandra Glucksmann

Alexandra (Sandra) Glucksmann is an accomplished professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Senior Advisor at Scenic Biotech and President & CEO at Sensorium Therapeutics, Alexandra has held numerous leadership roles, including Independent Board Member at REGENXBIO Inc. and Taconic, and President and CEO of Cedilla Therapeutics. With a background as an Entrepreneur In Residence at Third Rock Ventures and COO at Editas Medicine, Alexandra possesses a strong business acumen complemented by a robust academic foundation, holding a PhD in Molecular Genetics and Cell Biology from the University of Chicago and post-doctoral fellowship in Molecular Biology from the Massachusetts Institute of Technology. Notably, Alexandra has also contributed to the advancement of women in science and technology as a board member and chair at WEST - Women in the Enterprise of Science and Technology.